Wednesday, February 3, 2016

CMS Final Covered Outpatient Drug Rule Addresses Many Industry Concerns | The National Law Review

Read this very detailed analysis: CMS Final Covered Outpatient Drug Rule Addresses Many Industry Concerns | The National Law Review:

. . . "on January 21, 2016, nearly four years after publishing its proposed rule, CMS finalized the rule, which will take effect April 1, 2016.[1] The Final Rule implements changes to AMP that the ACA required, replaces the calculation methodology for AMP in the withdrawn Deficit Reduction Act (DRA) rule,[2] and provides additional rules for determining Best Price (BP) reported for innovator drugs and biological products."

'via Blog this'

Return Home:  The Designated Representative and Exemptee Blog




For Designated Representative license applicants  -  Training programs, courses, classes, seminars:

     California (earn a training affidavit):
     Florida:

For HMDR Exemptee license applicants  -  Training programs, courses, classes, seminars:

     California (earn a training completion certificate):

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Custom Search

From SkillsPlus International Inc.